skip to main content

S. 2917 (113th): Adding Ebola to the FDA Priority Review Voucher Program Act

This bill has 4 versions. Select a version to view:

Compare to a previous version to see how the bill has changed:

Compare this bill to another bill:

React to this bill with an emoji

Save your opinion on this bill on a six-point scale from strongly oppose to strongly support

Add Note All Positions »
(About Ads | Hide These Ads)

The text of the bill below is as of Dec 2, 2014 (Passed the Senate).

113th CONGRESS

2d Session

S. 2917

IN THE SENATE OF THE UNITED STATES

AN ACT

To expand the program of priority review to encourage treatments for tropical diseases.

1.

Short title

This Act may be cited as the Adding Ebola to the FDA Priority Review Voucher Program Act .

2.

Priority review to encourage treatments for tropical diseases

Section 524 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360n ) is amended—

(1)

in subsection (a)(3)—

(A)

by redesignating subparagraph (Q) as subparagraph (R);

(B)

by inserting after subparagraph (P) the following:

(Q)

Filoviruses.

; and

(C)

in subparagraph (R), as so redesignated, by striking regulation by and inserting order of; and

(2)

in subsection (b)—

(A)

in paragraph (2), by adding There is no limit on the number of times a priority review voucher may be transferred before such voucher is used. after the period at the end; and

(B)

in paragraph (4), by striking 365 days and inserting 90 days.

Passed the Senate December 2, 2014.

Secretary